Conversely, a recent report on lung cancer patients demonstrated that TXNIP was hypoxia inducible in lung cancer cell lines and that patients with high levels of TXNIP had significantly shorter PFS which was maintained in a multivariate analysis. The gene discussed is TXNIP; the disease is lung cancer.